Literature DB >> 16192453

Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension.

Cornelia Henke-Gendo1, Michael Mengel, Marius M Hoeper, Khaled Alkharsah, Thomas F Schulz.   

Abstract

RATIONALE: In addition to Kaposi's sarcoma, Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) has been associated with two other diseases: primary effusion lymphoma and the plasma cell variant of multicentric Castleman's disease. Recently, evidence of KSHV infection was reported in plexiform lesions of idiopathic pulmonary arterial hypertension (IPAH) as well as in adjacent parenchyma and bronchial epithelial cells.
OBJECTIVES: To further investigate a possible association of KSHV and pulmonary arterial hypertension. METHODS AND MEASUREMENTS: Twenty-six lungs explanted from German patients suffering from IPAH were tested for the presence of KSHV antigen and genomes by immunohistochemistry (IHC) and polymerase chain reaction (PCR). MAIN
RESULTS: When stained with a commercial monoclonal antibody directed against the latency-associated nuclear antigen of KSHV, LANA-1, a positive signal reminiscent of the "speckled" nuclear pattern typical of latently KSHV-infected cells was found in 16 (61.5%) cases. Alveolar and bronchial epithelial cells in areas of unremarkable lung tissue, but not cells within the plexiform lesions, were the predominantly stained cell types. Different KSHV-PCR assays (based on orf26, orfK6, and orf72) performed on samples that had tested positively in IHC, however, could not confirm KSHV infection, indicating that the IHC signal was not due to KSHV infection. One IHC-negative patient tested positive by PCR. A PCR based on consensus degenerate hybrid oligonucleotide primers (CODEHOP) to detect yet unknown gamma-herpesviruses did not reveal any specific sequences.
CONCLUSIONS: KSHV is unlikely to play a role in the pathogenesis of IPAH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16192453     DOI: 10.1164/rccm.200504-546OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  14 in total

Review 1.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

2.  Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells.

Authors:  Todd M Bull; Christina A Meadows; Christopher D Coldren; Mark Moore; Sylk M Sotto-Santiago; Serge P Nana-Sinkam; Thomas B Campbell; Mark W Geraci
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

Review 3.  The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.

Authors:  Nada Kherbeck; Mathieu C Tamby; Guillaume Bussone; Hanadi Dib; Frederic Perros; Marc Humbert; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 4.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

Review 5.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

6.  Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension.

Authors:  Priscilla Y Hsue; Steven G Deeks; Husam H Farah; Swapna Palav; Samira Y Ahmed; Amanda Schnell; Allison B Ellman; Laurence Huang; Sheila C Dollard; Jeffrey N Martin
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

Review 7.  Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes.

Authors:  Jian-Chao Zong; Ravit Arav-Boger; Donald J Alcendor; Gary S Hayward
Journal:  J Clin Virol       Date:  2007-08-14       Impact factor: 3.168

Review 8.  Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus.

Authors:  Benjamin J Dunmore; Rowena J Jones; Mark R Toshner; Paul D Upton; Nicholas W Morrell
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 10.787

9.  Human immunodeficiency virus, herpes virus infections, and pulmonary vascular disease.

Authors:  Sonia C Flores; Sharilyn Almodovar
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

10.  Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II.

Authors:  Hannah J Durrington; Paul D Upton; Simon Hoer; Jessica Boname; Benjamin J Dunmore; Jun Yang; Trina K Crilley; Lynn M Butler; David J Blackbourn; Gerard B Nash; Paul J Lehner; Nicholas W Morrell
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.